Brexit Timebomb: Expect Effects On Drug Regulation, IP, Research And Trade
This article was originally published in The Pink Sheet Daily
Executive Summary
The UK's decision to leave the EU will have a wide range of effects on the life sciences sector, from drug approvals and clinical research to data exclusivity, patents and trade.